Cost-effectiveness analysis of dapagliflozin for the treatment of type 2 diabetes mellitus in Spain: results of the DECLARE-TIMI 58 study

por Escobar, Carlos, Morales, Cristóbal, Capel, Margarita, Simón, Susana, Pérez-Alcántara, Ferran, Pomares, Elisenda
Publicado 2022

Efficacy of Dapagliflozin in Southern Europe Across the Spectrum of Characteristics of Type 2 Diabetes: An International Real-World Analysis

por Fadini, Gian Paolo, Morales, Cristobal, Caballero, Irene, González, Beatriz, Tentolouris, Nikolaos, Consoli, Agostino
Publicado 2022

Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain

por Morales, Cristóbal, de Luis, Daniel, de Arellano, Antonio Ramírez, Ferrario, Maria Giovanna, Lizán, Luis
Publicado 2015

Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D

por González-Albarrán, Olga, Morales, Cristóbal, Pérez-Maraver, Manuel, Aparicio-Sánchez, José Juan, Simó, Rafael
Publicado 2022

Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and S...

por Conget, Ignacio, Mangas, Miguel Ángel, Morales, Cristóbal, Caro, Juan, Giménez, Margarita, Borrell, Mireia, Delgado, Elías
Publicado 2021

Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

por Gomez-Peralta, Fernando, Abreu, Cristina, Lecube, Albert, Bellido, Diego, Soto, Alfonso, Morales, Cristóbal, Brito-Sanfiel, Miguel, Umpierrez, Guillermo
Publicado 2017

Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

por Gomez-Peralta, Fernando, Abreu, Cristina, Lecube, Albert, Bellido, Diego, Soto, Alfonso, Morales, Cristóbal, Brito-Sanfiel, Miguel, Umpierrez, Guillermo
Publicado 2017

Descriptive study of a clinical and educational telemedicine intervention in patients with diabetes receiving glargine 300 U/ml (Toujeo) in Spain: results of the T-Coach programme

por Bellido, Virginia, Morales, Cristóbal, Garach, Araceli Muñoz, Almeida, José Manuel García, Morera, Juan Luis Fernández, Aguilera, Beatriz González, de la Torre, Martín López, Bellido, Diego
Publicado 2023

Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

por Morales, Cristóbal, Merino-Torres, Juan Francisco, Moreno-Moreno, Paloma, Lainez, María, Tejado, Iñigo, Yoldi, Alfredo, Gutiérrez Medina, Sonsoles, Soto, Alfonso, Botana, Manuel A, Bellido, Virginia, Caballero, Irene
Publicado 2022

Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study

por García de Lucas, María Dolores, Caballero, Irene, Fernández-García, José Carlos, Domínguez-Rodríguez, Manuel, Moreno-Moreno, Paloma, Jiménez-Millán, Anabel, Botana-López, Manuel, Avilés, Beatriz, Merino-Torres, Juan Francisco, Soto, Alfonso, Tejera, Cristina, Morales, Cristóbal
Publicado 2023

Effects of a Digital Patient Empowerment and Communication Tool on Metabolic Control in People With Type 2 Diabetes: The DeMpower Multicenter Ambispective Study

por Orozco-Beltrán, Domingo, Morales, Cristóbal, Artola-Menéndez, Sara, Brotons, Carlos, Carrascosa, Sara, González, Cintia, Baro, Óscar, Aliaga, Alberto, Ferreira de Campos, Karine, Villarejo, María, Hurtado, Carlos, Álvarez-Ortega, Carolina, Gómez-García, Antón, Cedenilla, Marta, Fernández, Gonzalo
Publicado 2022